Isorhamnetin induces the paraptotic cell death through ROS and the ERK/MAPK pathway in OSCC cells.
Qian ChenShaojuan SongZhen WangYingqiang ShenLiang XieJing LiLu JiangHang ZhaoXiaodong FengYu ZhouMin ZhouXin ZengNing JiQian-Ming ChenPublished in: Oral diseases (2020)
Our study suggested that the anti-cancer effect of isorhamnetin might trigger paraptosis, which may indicate a new therapeutic approach to OSCC.